LOS ANGELES, March 19, 2018 -- LegalMation, pioneering developer of the first artificial intelligence solution that automates early stage litigation tasks through the use of innovative IBM Watson technology, will be exhibiting and demonstrating its capabilities at IBM Think 2018. The conference will be held from March 19-22 at the Mandalay Bay Resort and Casino in Las Vegas.
One of the only legal industry innovations invited to speak at IBM Think, LegalMation was developed by award-winning litigation experts and is the only A.I. solution that produces actual first drafts of key litigation documents—a fully automated process that takes only 60-120 seconds. With no installation required or specialized functions to learn, LegalMation identifies key claims and allegations in filed complaints and then produces high-quality first drafts of answers and initial written discovery. This constitutes cost savings of several thousands of dollars per matter and is a game-changer for in-house legal departments and law firms alike wrestling with a high-volume caseload.
Proudly embracing the “With Watson” designation, a distinction granted to only five percent of companies using Watson, LegalMation will be featured and presented as one of IBM’s top “use cases” in one of the 10 scheduled “Small Core Sessions.” Co-founder and CEO James M. Lee will also speak regarding the use of artificial intelligence solutions in the legal market overall and how LegalMation is disrupting the industry.
LegalMation will be featured at an activation kiosk and pedestal demos on the floor of the Mandalay Bay Convention Center.
About LegalMation
LegalMation is a California-based technology company. It is led by a group of experienced lawyers and technology specialists, dedicated to revolutionizing the practice of law through technology aimed at both in-house legal departments and law firms. For more information, visit www.legalmation.com.
Contact: Penny Desatnik
Blattel Communications
415.413.4509
[email protected]


Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



